National Research Q4 revenue +10% to $38.3M, EPS $0.38; FY revenue +11% to $148.0M

NRC HEALTH

2021-FY EPS reported $1.46 revenue$147,954,000

Q4 2021 revenue $38.3M (+10% YoY); operating income $12.9M (+26%); diluted EPS $0.38 vs $0.32.
Full-year 2021 revenue $148.0M (+11%); operating income $50.3M (+18%); diluted EPS $1.46 vs $1.45.
Cash flow from operations $46.3M (up 14%); net cash position $27.8M, up from $4.1M at year-end 2020.
Launched Health's Human Understanding Program to personalize patient care at scale.
Continued quarterly dividend and share repurchases funded by strong cash flow.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.